When should a pregnant woman or a woman planning to become pregnant start taking iron and folic acid supplements?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Start Iron and Folic Acid Supplementation in Pregnancy

Universal Recommendation for All Women of Reproductive Age

All women of childbearing age (12-45 years) who could become pregnant should begin taking 400-800 μg (0.4-0.8 mg) of folic acid daily immediately, regardless of pregnancy plans, because over 50% of pregnancies are unplanned and neural tube closure occurs within the first 28 days after conception—often before pregnancy is recognized. 1, 2

Standard-Risk Women (Low Risk)

  • Women without specific risk factors should take 400-800 μg (0.4-0.8 mg) of folic acid daily, starting at least 4 weeks (ideally 2-3 months) before planned conception and continuing through the first trimester (12 weeks of pregnancy). 1, 3

  • After 12 weeks of gestation, continue supplementation at 400-800 μg daily throughout pregnancy and for 4-6 weeks postpartum or as long as breastfeeding continues. 4

  • This supplementation should be taken in addition to consuming folic acid-fortified foods. 1

High-Risk Women Requiring Higher Doses

Women with any of the following risk factors require 4,000-5,000 μg (4-5 mg) of folic acid daily, starting at least 12 weeks (3 months) before conception:

  • Personal history of neural tube defect 1, 2, 5
  • Prior pregnancy affected by neural tube defect 1, 5, 4
  • First- or second-degree relative with neural tube defect 1, 2
  • Male partner with personal history of neural tube defect 4
  • Type 1 diabetes mellitus 1
  • Exposure to high-risk medications during early pregnancy, including antiepileptic drugs (valproic acid, carbamazepine, lamotrigine) 1, 2
  • Prior pregnancy with hydrocephalus 5

Critical Dosing Algorithm for High-Risk Women

  • Preconception through 12 weeks gestation: 4,000-5,000 μg (4-5 mg) folic acid daily 1, 2, 4

  • After 12 weeks gestation through delivery: Reduce to 400-1,000 μg (0.4-1.0 mg) daily to decrease potential health consequences of long-term high-dose folic acid ingestion 2, 5, 4

  • Postpartum: Continue 400-1,000 μg daily for 4-6 weeks or as long as breastfeeding continues 4

Iron Supplementation Timing

  • Iron supplementation (typically 60 mg elemental iron) should be initiated when folic acid supplementation begins, particularly for women in populations where anemia prevalence exceeds 20%. 6, 7

  • Daily iron supplementation is more effective than intermittent regimens for preventing anemia at term, though both are acceptable. 7

Important Safety Considerations

Vitamin B12 Screening

  • Before prescribing folic acid doses exceeding 1 mg daily, vitamin B12 deficiency should be ruled out, as folic acid doses above 0.1 mg may obscure pernicious anemia while neurologic damage progresses. 2, 8

  • However, vitamin B12 deficiency is uncommon in young women of reproductive age, and investigations are generally not required before initiating supplementation if folic acid is taken in a multivitamin containing 2.6 μg/day of vitamin B12. 2, 4

Dosing Precautions for High-Risk Women

  • Women requiring more than 1 mg folic acid should take only one multivitamin tablet per day (to avoid excessive intake of other vitamins) and achieve the desired folic acid dose by adding separate folic acid-only tablets. 4

  • Total daily folic acid intake should not exceed 1,000 μg unless prescribed by a physician for high-risk conditions. 3, 8

Common Pitfalls to Avoid

  • Starting supplementation after pregnancy recognition is too late—neural tube closure is complete by 28 days post-conception (approximately 6 weeks from last menstrual period), before many women realize they're pregnant. 1, 5

  • Underestimating risk factors—women taking antiepileptic medications or with family history of neural tube defects in second-degree relatives (such as cousins) require high-dose supplementation, not standard doses. 2

  • Discontinuing high-dose supplementation too early—high-risk women must continue 4-5 mg daily through the entire first trimester (12 weeks), not just until pregnancy confirmation. 1, 5

Evidence Strength and Limitations

  • Folic acid supplementation prevents approximately 50-72% of neural tube defect cases, but even with adequate supplementation, some cases cannot be prevented due to multifactorial or monogenic etiology. 2, 5

  • The 4-5 mg dose recommendation for high-risk women is based on the landmark British MRC Vitamin Study, which demonstrated that high-dose folic acid prevents recurrence of neural tube defects. 5

  • Side effects (gastrointestinal symptoms) and haemoconcentration (hemoglobin >130 g/L) are more common with daily iron supplementation, though the clinical significance of haemoconcentration remains uncertain. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Folic Acid Supplementation Guidelines for Women with Epilepsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Folic Acid Supplementation for Pre-Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015

Guideline

Folic Acid Supplementation for Neural Tube Defect Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.